TEXAS (Taxotere® EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC

Author： Malinovszky K.   Johnston S.   Barrett-Lee P.   Howell A.   Verrill M.   O’Reilly S.   Houston S.   Wardley A.   Grieve R.   Leonard R.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.3, 2007-03, pp. : 413-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cardiac Toxicity of Antineoplastic Anthracyclines

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 2, 2003-03 ,pp. : 151-171

Bentham Science Publishers

Access to resources Recommend Favorite

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

By Diéras Véronique   Guastalla Jean   Ferrero Jean   Curé Hervé   Weber Béatrice   Winckel Philippe   Lortholary Alain   Mayer Françoise   Paraiso Désiré   Magherini Emmanuelle   Pujade-Lauraine Eric  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 489-495

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

By Hortobagyi Gabriel   Gomez Henry   Li Rubi   Chung Hyun-Cheol   Fein Luis   Chan Valorie   Jassem Jacek   Lerzo Guillermo   Pivot Xavier   Hurtado de Mendoza Fernando   Xu Binghe   Vahdat Linda   Peck Ronald   Mukhopadhyay Pralay   Roché Henri  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 409-418

Springer Publishing Company

Access to resources Recommend Favorite

The Use of Anthracyclines for Therapy of CNS Tumors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-07 ,pp. : 721-727

Bentham Science Publishers

Access to resources Recommend Favorite

Docetaxel and cisplatin combination chemotherapy in anthracyclines-resistant advanced breast cancer

By Xiong Hailin   Liu Zhujun   Cheng Xin   Li Kai  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 1, 2007-02 ,pp. : 55-58

Springer Publishing Company

Access to resources Recommend Favorite